Cue Biopharma, Inc. (31) | Business Operations (13)
Browse by Subcategory
Recent Contracts
-
First Amendment to Collaboration, License and Option Agreement, dated March 15, 2019, between the Registrant and LG CHEM LTD
(Filed With SEC on March 9, 2021)
-
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated June 22, 2020
(Filed With SEC on June 22, 2020)
-
Second Amendment to Collaboration, License and Option Agreement, dated August 5, 2019, between the Registrant and LG CHEM LTD
(Filed With SEC on March 9, 2021)
-
Third Amendment to Collaboration, License and Option Agreement, dated October 29, 2019, between the Registrant and LG CHEM LTD
(Filed With SEC on March 9, 2021)
-
Fourth Amendment to Collaboration, License and Option Agreement, dated December 18, 2019, between the Registrant and LG CHEM LTD
(Filed With SEC on March 9, 2021)
-
Fifth Amendment to Collaboration, License and Option Agreement, dated January 10, 2020, between the Registrant and LG CHEM LTD
(Filed With SEC on March 9, 2021)
-
Sixth Amendment to Collaboration, License and Option Agreement, dated February 14, 2020, between the Registrant and LG CHEM LTD
(Filed With SEC on March 9, 2021)
-
Seventh Amendment to Collaboration, License and Option Agreement, dated May 14, 2020, between the Registrant and LG CHEM LTD
(Filed With SEC on March 9, 2021)
-
Eighth Amendment to Collaboration, License and Option Agreement, dated December 7, 2020, between the Registrant and LG CHEM LTD
(Filed With SEC on March 9, 2021)
-
First Amendment to the Exclusive Patent License and Research Collaboration Agreement with Merck Sharp & Dohme Corp. dated November 9, 2020
(Filed With SEC on March 9, 2021)
-
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated March 27, 2020
(Filed With SEC on March 27, 2020)
-
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated November 25, 2019
(Filed With SEC on November 26, 2019)
-
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated June 5, 2019
(Filed With SEC on June 5, 2019)